论文部分内容阅读
在世界药物近十年的发展中,出现了一个引起国际制药界和医学界高度注意的药物,即“头孢克洛”(英文名,CEFA-CLOR,缩写:CCL),CEFA-CLOR于1976年由美国开发,1979年获FDA批准,1982年在美国上市,1985年即替代头孢氨苄成为当年世界畅销抗菌药物第一名,据美国《Scrip》与《MarketLetter》两大世界权威性的医药信息杂志追踪报道,1987年-1993年CEFACLOR连续8个年度作为世界第一畅销抗菌药排入世界十大畅销
In the past ten years of drug development in the world, there was a drug that attracted great attention from the international pharmaceutical and medical communities, namely “cefaclor” (English name, CEFA-CLOR, abbreviation: CCL), and CEFA-CLOR in 1976 Developed by the United States, approved by the FDA in 1979 and listed in the United States in 1982, cephalosporin was the best-selling antibacterial drug in 1985 in the United States. According to the authoritative medical information magazine Scrip and MarketLetter in the United States, Follow-up reports, 1987 - 1993 CEFACLOR for the eighth consecutive year as the world’s top-selling antibacterial drugs into the world’s top ten best-selling